Transit Analysis for Shuttle Schedule Optimization
ID: 75F40124R00117Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONRockville, MD, 20841, US

NAICS

Bus and Other Motor Vehicle Transit Systems (485113)

PSC

TRANSPORTATION R&D SERVICES; SURFACE TRANSPORTATION, PUBLIC TRANSIT, AND RAIL; BASIC RESEARCH (AS11)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)

Original Source

https://sam.gov/opp/108502d51e3e4a719b7be5f25c0c529e/view
Timeline
    Description

    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking a service for Transit Analysis for Shuttle Schedule Optimization. This service is typically used to conduct an analysis of all relevant transit options within the FDA White Oak Campus service area in Silver Spring, Maryland. The objective is to update and modify FDA Commuter and Circulator Shuttle Bus schedules based on the analysis results, supplementing the services provided by local public transit agencies and filling gaps in service. Interested parties have seven days to respond to this notice. The closing date for responses is June 17, 2024, 12:00 PM EST.

    Point(s) of Contact
    Natapol Sirikhan
    (240) 402-8031
    Natapol.Sirikhan@fda.hhs.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Transit Analysis for Shuttle Schedule Optimization
    Currently viewing
    Special Notice
    Similar Opportunities
    Request for Information (RFI) Application Programing Interface (API) Enterprise Management Solutions
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking information regarding Application Programming Interface (API) Enterprise Management Solutions to support its enterprise-wide API strategy. The primary objective of this Request for Information (RFI) is to gather insights on existing or potential solutions that can standardize and streamline the management of APIs currently dispersed throughout the organization, with a focus on scalability, security, and total cost of ownership. This initiative is crucial for modernizing legacy systems and enhancing operational efficiency within the FDA. Interested vendors are encouraged to submit their responses by December 20, 2024, and can direct inquiries to Noah Padilla at Noah.Padilla@fda.hhs.gov.
    Q201--Wheelchair Van Transportation Services
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified service providers to deliver Wheelchair Van Transportation Services for the VA Maryland Healthcare System located in Baltimore, Maryland. This procurement aims to establish a Firm-Fixed-Price contract valued at up to $19 million, specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB), to ensure 24/7 transportation services for eligible veterans while adhering to all applicable regulations and performance standards. The contract emphasizes the importance of high-quality service delivery, with strict specifications regarding service hours, vehicle requirements, and personnel qualifications, reflecting the government's commitment to providing essential services to veterans. Interested parties must submit their bids by December 13, 2024, at 15:00 Eastern Time, and can reach out to the contracting officer, Craig Armagost, at craig.armagost@va.gov for further inquiries.
    HHS ONE PROFESSIONAL SERVICES SOLUTION (HOPSS)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and the National Institute on Drug Abuse (NIDA), is seeking qualified small businesses to provide professional services under the HHS One Professional Services Solution (HOPSS). The procurement aims to support HHS's strategic goals from 2022 to 2026, focusing on enhancing healthcare access, improving public health outcomes, and fostering equity through two primary task areas: Science, Technology, Engineering and Math (STEM) services, and Business and Operational Services to support STEM activities. This initiative is critical for advancing research and operational efficiencies across various HHS divisions, with a total contract value anticipated to be significant, as it builds on a history of complex service contracts. Interested small businesses must submit a written capability statement and complete a mandatory survey by December 9, 2024, at 1:00 PM ET, with further inquiries directed to Kyle Miller at kyle.miller2@nih.gov.
    BIL Funded - Program and Project Schedule Analysis (Forensic Scheduler)
    Active
    Transportation, Department Of
    The Department of Transportation, specifically the Federal Aviation Administration (FAA), is seeking proposals for program and project schedule analysis services under the Bipartisan Infrastructure Law (BIL) for the replacement and modernization of Airport Traffic Control Towers (ATCT) and Terminal Facilities. The contract, structured as an Indefinite Delivery Indefinite Quantity (IDIQ), aims to engage a qualified Scheduling/Forensic Scheduling firm to provide expert analysis throughout various project stages, ensuring compliance with timelines and material obligations. This initiative is crucial for enhancing air traffic control infrastructure, with a total contract ceiling of $4.5 million and a minimum ordering obligation of $100,000. Interested firms must submit their proposals by December 27, 2024, and direct any inquiries to Ms. Katherine Fogle and Ms. Thuylinh TranNguyen by December 11, 2024.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Partnership for Analytics Research in Traffic Safety (PARTS)
    Active
    Transportation, Department Of
    The Department of Transportation, through the Volpe National Transportation Systems Center, is soliciting proposals for the Partnership for Analytics Research in Traffic Safety (PARTS) program, aimed at enhancing vehicle safety performance analysis by leveraging both federal and non-federal data. The contractor will be responsible for project management, partnership maintenance, data ingestion, analysis, and communication/reporting, with a focus on advanced driver-assistance systems (ADAS) to improve transportation safety and technology impacts. This fixed-price contract is set to commence on January 1, 2025, and conclude on December 31, 2026, with a sole-source justification for Mitre, a Federally Funded Research and Development Center, due to their unique expertise and previous involvement in the program. Interested parties can reach out to Andrew J. Josephs at andrew.josephs@dot.gov or Matthew Phelps at matthew.phelps@dot.gov for further information.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    CC-NAMAXXX-26 Concession Business Opportunity to provide Interpretive Transportation Services at National Mall and Memorial Parks, located in Washington, DC.
    Active
    Interior, Department Of The
    The Department of the Interior, through the National Park Service, is soliciting proposals for up to three Concessions Contracts to provide interpretive transportation services at the National Mall and Memorial Parks in Washington, DC. The selected offerors will be responsible for delivering year-round hop-on and hop-off tour services that include a minimum of 11 designated stops at significant national landmarks, such as the Washington Monument and the Lincoln Memorial. This opportunity is crucial for enhancing visitor experience at one of the nation's most iconic parklands, which attracts thousands of visitors daily. Interested parties must notify the National Capital Region Concessions Program Manager, Jason Freeze, by December 27, 2024, and submit their proposals by January 10, 2025, to be considered for this opportunity.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This initiative seeks to acquire innovative research proposals that enhance scientific knowledge and support the FDA's mission to protect public health, with a focus on areas such as product development, post-market surveillance, and public health preparedness. Interested parties, particularly small businesses, are encouraged to submit detailed Stage One Submittal Packages, including concept papers and full proposals, by February 24, 2025. For further inquiries, applicants can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728.